Walleye Trading LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 140 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2018$5,000
-98.2%
474
-98.5%
0.00%
-100.0%
Q3 2017$274,000
-33.5%
30,800
-21.4%
0.00%
-66.7%
Q1 2017$412,000
-11.0%
39,200
-22.1%
0.00%0.0%
Q4 2016$463,000
+7616.7%
50,300
+9960.0%
0.00%
Q3 2016$6,000
+500.0%
500
+1251.4%
0.00%
Q3 2015$1,000370.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2016
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,257,094$92,697,00013.04%
JW Asset Management, LLC 388,346$11,052,0004.00%
Anson Funds Management LP 400,200$11,390,0003.31%
Orbimed Advisors 4,081,800$116,168,0001.17%
SCOPIA CAPITAL MANAGEMENT LP 1,718,487$48,908,0001.05%
Bellevue Asset Management AG 210,000$5,977,0000.98%
NEXT CENTURY GROWTH INVESTORS LLC 788,534$22,441,0000.93%
Rock Springs Capital Management LP 308,000$8,766,0000.71%
JUNCTURE WEALTH STRATEGIES, LLC 18,502$527,0000.43%
B. Riley Wealth Management, Inc. 8,600$244,0000.35%
View complete list of INSYS THERAPEUTICS INC NEW shareholders